INVA FY 2025 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$425M+18.5% YoY

Gross Profit

$308M72.3% margin

Operating Income

$164M38.5% margin

Net Income

$271M63.8% margin

EPS (Diluted)

$3.30

Cash Flow

Operating Cash Flow

$197M

Free Cash Flow

$196M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$462M

Stockholders' Equity

$1.2B

Cash & Equivalents

$551M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$425M	$359M	+18.5%
Gross Profit	$308M	$322M	-4.5%
Operating Income	$164M	$167M	-1.9%
Net Income	$271M	$23M	+1059.2%